(Q35025684)

5 August 2017

title

Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma (English)

1 reference

5 August 2017

main subject

lymphoblastic leukemia

1 reference

J P Vieira Pinheiro

1

1 reference

5 August 2017

C Lanversa

2

1 reference

5 August 2017

G Würthwein

3

1 reference

5 August 2017

R Beier

4

1 reference

5 August 2017

J Casimiro da Palma

5

1 reference

5 August 2017

A von Stackelberg

6

1 reference

5 August 2017

J Boos

7

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

43

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1911-1920

1 reference

Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapy

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

L-Asparaginase and L-Asparagine Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

21 January 2018

Asparaginase revisited

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Use of ?-asparaginase in childhood ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Toxicity of E. coli L-asparaginase in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Pegaspargase: an alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

L-asparaginase and PEG asparaginase--past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000015853

10.1080/1042819021000015853

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference